Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients

[1]  S. Teichmann,et al.  A cell atlas of human thymic development defines T cell repertoire formation , 2020, Science.

[2]  F. Schuetz,et al.  Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer , 2019, Cancer Immunology Research.

[3]  M. Feldmann,et al.  TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells , 2019, Proceedings of the National Academy of Sciences.

[4]  S. Berger,et al.  TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion , 2019, Nature.

[5]  Yufeng Shen,et al.  Crossreactive public TCR sequences undergo positive selection in the human thymic repertoire. , 2019, The Journal of clinical investigation.

[6]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[7]  Melissa J. Davis,et al.  TCF-1 limits the formation of Tc17 cells via repression of the MAF–RORγt axis , 2019, The Journal of experimental medicine.

[8]  M. Manirujjaman,et al.  Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions , 2019, International journal of molecular sciences.

[9]  A. Rao,et al.  Loss of TET2 and TET3 in regulatory T cells unleashes effector function , 2019, Nature Communications.

[10]  A. Yoshimura,et al.  Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression. , 2019, International immunology.

[11]  A. Richmond,et al.  Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy , 2019, Front. Immunol..

[12]  R. Rad,et al.  Blimp1 Prevents Methylation of Foxp3 and Loss of Regulatory T Cell Identity at Sites of Inflammation , 2019, Cell reports.

[13]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases in health and disease☆ , 2019, Biochimica et biophysica acta. Molecular cell research.

[14]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[15]  Xueda Hu,et al.  Lineage tracking reveals dynamic relationships of T cells in colorectal cancer , 2018, Nature.

[16]  T. Zhu,et al.  Preventative tracheal administration of interleukin‐27 attenuates allergic asthma by improving the lung Th1 microenvironment , 2018, Journal of cellular physiology.

[17]  W. Wen,et al.  Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis , 2018, Cancer Immunology, Immunotherapy.

[18]  Florent Ginhoux,et al.  A Single-Cell Sequencing Guide for Immunologists , 2018, Front. Immunol..

[19]  S. Matsuda,et al.  Human Sox4 facilitates the development of CXCL13-producing helper T cells in inflammatory environments , 2018, Nature Communications.

[20]  T. Winkler,et al.  CD83 expression is essential for Treg cell differentiation and stability. , 2018, JCI insight.

[21]  Amit Sharma,et al.  Emerging Functions of Regulatory T Cells in Tissue Homeostasis , 2018, Front. Immunol..

[22]  Sean S. Park,et al.  CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. , 2018, JCI insight.

[23]  R. Flavell,et al.  ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates , 2018, The Journal of experimental medicine.

[24]  A. B. Lyons,et al.  Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major , 2018, Front. Immunol..

[25]  Beth Walters,et al.  Foxp1 Negatively Regulates T Follicular Helper Cell Differentiation and Germinal Center Responses by Controlling Cell Migration and CTLA-4 , 2018, The Journal of Immunology.

[26]  T. Morita,et al.  Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis , 2018, Molecular Cancer Research.

[27]  E. García-Zepeda,et al.  TβRIII is induced by TCR signaling and downregulated in FoxP3+ regulatory T cells. , 2017, Biochemical and biophysical research communications.

[28]  A. Rudensky,et al.  A nonimmune function of T cells in promoting lung tumor progression , 2017, The Journal of experimental medicine.

[29]  Yan Kang,et al.  Tregs: Where We Are and What Comes Next? , 2017, Front. Immunol..

[30]  Yufeng Shen,et al.  Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. , 2017, Cell reports.

[31]  Harini Veeraraghavan,et al.  Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient , 2017, Cell.

[32]  Hannah A. Pliner,et al.  Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.

[33]  C. Plass,et al.  Genome-wide DNA methylation landscape defines specialization of regulatory T cells in tissues , 2017, Nature Immunology.

[34]  Y. Tu,et al.  A novel indication of thioredoxin-interacting protein as a tumor suppressor gene in malignant glioma , 2017, Oncology letters.

[35]  Shimin Wang,et al.  Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis , 2017, Oncotarget.

[36]  F. Sánchez‐Madrid,et al.  CD69: from activation marker to metabolic gatekeeper , 2017, European journal of immunology.

[37]  R. Brink,et al.  In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors , 2017, Proceedings of the National Academy of Sciences.

[38]  R. Wu,et al.  MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer , 2017, Oncotarget.

[39]  Keji Zhao,et al.  The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination , 2017, The Journal of experimental medicine.

[40]  Russell B. Fletcher,et al.  Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics , 2017, BMC Genomics.

[41]  C. Weyand,et al.  Successful and Maladaptive T Cell Aging. , 2017, Immunity.

[42]  J. Lieberman,et al.  Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer , 2017, Cell Research.

[43]  F. Schuetz,et al.  Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1 , 2017, Cancer Immunology, Immunotherapy.

[44]  Jun Li,et al.  Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer , 2017, Breast Cancer Research.

[45]  Andrew J. Hill,et al.  Single-cell mRNA quantification and differential analysis with Census , 2017, Nature Methods.

[46]  S. Sakaguchi,et al.  Regulatory T cells in cancer immunotherapy , 2016, Cell Research.

[47]  G. Plitas,et al.  Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer. , 2016, Immunity.

[48]  H. Stunnenberg,et al.  Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells , 2016, Immunity.

[49]  Z. Yao,et al.  Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer , 2016, Oncotarget.

[50]  Iain C Macaulay,et al.  Separation and parallel sequencing of the genomes and transcriptomes of single cells using G&T–seq , 2016, Nature Protocols.

[51]  Mauricio Barahona,et al.  SC3 - consensus clustering of single-cell RNA-Seq data , 2016, Nature Methods.

[52]  Mikhail Shugay,et al.  Dynamics of Individual T Cell Repertoires: From Cord Blood to Centenarians , 2016, The Journal of Immunology.

[53]  J. Cyster,et al.  EBI2 augments Tfh cell fate by promoting interaction with IL2-quenching dendritic cells , 2016, Nature.

[54]  Anneliese O. Speak,et al.  T cell fate and clonality inference from single cell transcriptomes , 2016, Nature Methods.

[55]  D. Glass,et al.  Transcriptome profiling of human FoxP3+ regulatory T cells. , 2016, Human immunology.

[56]  I. Hellmann,et al.  Comparative Analysis of Single-Cell RNA Sequencing Methods , 2016, bioRxiv.

[57]  Nikhil S. Joshi,et al.  The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection , 2015, The Journal of experimental medicine.

[58]  Mauricio Barahona,et al.  SC 3 - consensus clustering of single-cell RNA-Seq data , 2015 .

[59]  V. De Rosa,et al.  Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants , 2015, Nature Immunology.

[60]  Christof von Kalle,et al.  High-resolution analysis of the human T-cell receptor repertoire , 2015, Nature Communications.

[61]  Xiaogang Wang,et al.  Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma , 2015, Oncoimmunology.

[62]  S. Zheng,et al.  The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells , 2015, Cellular and Molecular Immunology.

[63]  J. Hoeijmakers,et al.  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. , 2014, Developmental cell.

[64]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[65]  Mark M Davis,et al.  Linking T-cell receptor sequence to functional phenotype at the single-cell level , 2014, Nature Biotechnology.

[66]  Deepali V. Sawant,et al.  Once a Treg, always a Treg? , 2014, Immunological reviews.

[67]  S. Sakaguchi,et al.  Regulatory T cells in cancer immunotherapy. , 2014, Current opinion in immunology.

[68]  Olga V. Britanova,et al.  Age-Related Decrease in TCR Repertoire Diversity Measured with Deep and Normalized Sequence Profiling , 2014, The Journal of Immunology.

[69]  Åsa K. Björklund,et al.  Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.

[70]  Olga V. Britanova,et al.  Preparing Unbiased T-Cell Receptor and Antibody cDNA Libraries for the Deep Next Generation Sequencing Profiling , 2013, Front. Immunol..

[71]  N. Sugimoto,et al.  DUSP4 Stabilizes FOXP3 Expression In Human Regulatory T Cells , 2013 .

[72]  X. Li,et al.  CD4+CD62L+ Central Memory T Cells Can Be Converted to Foxp3+ T Cells , 2013, PloS one.

[73]  Mikhail Shugay,et al.  MiTCR: software for T-cell receptor sequencing data analysis , 2013, Nature Methods.

[74]  Hiroyoshi Nishikawa,et al.  Natural and Induced T Regulatory Cells in Cancer , 2013, Front. Immunol..

[75]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[76]  F. Schuetz,et al.  HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients , 2013, Oncoimmunology.

[77]  M. Hickey,et al.  Deficiency of Annexin A1 in CD4+ T Cells Exacerbates T Cell–Dependent Inflammation , 2013, The Journal of Immunology.

[78]  A. Westendorf,et al.  HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. , 2012, International immunology.

[79]  George Coukos,et al.  T-regulatory cells: key players in tumor immune escape and angiogenesis. , 2012, Cancer research.

[80]  Gavin I. Ellis,et al.  Generation of induced regulatory T cells from primary human naïve and memory T cells. , 2012, Journal of visualized experiments : JoVE.

[81]  J. Lafaille,et al.  Induced CD4+Foxp3+ regulatory T cells in immune tolerance. , 2012, Annual review of immunology.

[82]  D. Hume,et al.  Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. , 2012, Blood.

[83]  C. Desmarais,et al.  Ultra-sensitive detection of rare T cell clones. , 2012, Journal of immunological methods.

[84]  F. Marincola,et al.  Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits CD8+ T cell memory formation , 2011, Nature Immunology.

[85]  Zuqiang Liu,et al.  Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity , 2011, The Journal of Immunology.

[86]  Haikun Wang,et al.  Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells , 2011, Nature Immunology.

[87]  M. Taketo,et al.  Runx3 Is Required for Full Activation of Regulatory T Cells To Prevent Colitis-Associated Tumor Formation , 2011, The Journal of Immunology.

[88]  J. Cheng,et al.  Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling , 2011, Nature.

[89]  Daniel C Douek,et al.  Bias in the αβ T‐cell repertoire: implications for disease pathogenesis and vaccination , 2011, Immunology and cell biology.

[90]  Stephan Wolf,et al.  Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing , 2010, Nature Protocols.

[91]  A. Giaccia,et al.  Hypoxia, inflammation, and the tumor microenvironment in metastatic disease , 2010, Cancer and Metastasis Reviews.

[92]  Y. Kanda,et al.  Biased usage of BV gene families of T‐cell receptors of WT1 (Wilms’ tumor gene)‐specific CD8+ T cells in patients with myeloid malignancies , 2010, Cancer science.

[93]  J. Chun,et al.  T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow , 2009, The Journal of experimental medicine.

[94]  T. Nomura,et al.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.

[95]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[96]  M. A. Curotto de Lafaille,et al.  Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? , 2009, Immunity.

[97]  A. Rudensky,et al.  Control of regulatory T cell lineage commitment and maintenance. , 2009, Immunity.

[98]  P. Cresswell,et al.  Viperin is required for optimal Th2 responses and T-cell receptor-mediated activation of NF-kappaB and AP-1. , 2009, Blood.

[99]  K. Kretschmer,et al.  DNA methylation controls Foxp3 gene expression , 2008, European journal of immunology.

[100]  Mushtaq Ahmed,et al.  Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus , 2008, The Journal of experimental medicine.

[101]  P. Halloran,et al.  The Transcriptome of Human Cytotoxic T Cells: Similarities and Disparities Among Allostimulated CD4+ CTL, CD8+ CTL and NK cells , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[102]  B. Kyewski,et al.  Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism , 2008, Proceedings of the National Academy of Sciences.

[103]  F. Schmidt.  Meta-Analysis , 2008 .

[104]  Hanno Glimm,et al.  High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.

[105]  P. Fink,et al.  A New Class of Reverse Signaling Costimulators Belongs to the TNF Family , 2007, The Journal of Immunology.

[106]  I. Türbachova,et al.  DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells , 2007, European journal of immunology.

[107]  Nitin J. Karandikar,et al.  Transient regulatory T-cells: a state attained by all activated human T-cells. , 2007, Clinical immunology.

[108]  Edgar Schmitt,et al.  Epigenetic Control of the foxp3 Locus in Regulatory T Cells , 2007, PLoS biology.

[109]  Stephen B Fox,et al.  Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  P. Doherty,et al.  Structural determinants of T-cell receptor bias in immunity , 2006, Nature Reviews Immunology.

[111]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[112]  W. Selby,et al.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.

[113]  J. Lohr,et al.  Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigen , 2005, The Journal of experimental medicine.

[114]  M. Büchler,et al.  High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients. , 2005, Cancer research.

[115]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[116]  P. Altevogt,et al.  Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors , 2004 .

[117]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[118]  M. Magnasco,et al.  Production of ribosome components in effector CD4+ T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK. , 2003, Immunity.

[119]  A. Cumano,et al.  The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct. , 2003, Immunity.

[120]  T. Eberlein,et al.  Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1 , 2002, The Journal of Immunology.

[121]  R. Küppers,et al.  Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor- beta gene rearrangements. , 2001, The American journal of pathology.

[122]  G. Bastert,et al.  Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow , 2001, Nature Medicine.

[123]  Hans Lassmann,et al.  Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.

[124]  J. Puente,et al.  Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer , 2000, British Journal of Cancer.

[125]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[126]  M. Watson,et al.  Mammaglobin expression in primary, metastatic, and occult breast cancer. , 1999, Cancer research.

[127]  K. Rajewsky,et al.  Amplification of TCRβ gene rearrangements from micromanipulated single cells: T cells rosetting around Hodgkin and Reed‐Sternberg cells in Hodgkin's disease are polyclonal , 1998 .

[128]  B. Kissela,et al.  Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. , 1994, Journal of immunology.

[129]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[130]  D. Mougiakakos,et al.  Regulatory T cells in cancer. , 2010, Advances in cancer research.

[131]  M. Rincón,et al.  The effects of IL-6 on CD4 T cell responses. , 2009, Clinical immunology.

[132]  C. Weyand,et al.  Age, T-cell Homeostasis, and T-cell Diversity in Humans , 2009 .

[133]  A. Solow,et al.  Measuring biological diversity , 2006, Environmental and Ecological Statistics.

[134]  P. Altevogt,et al.  Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors. , 2004, The Journal of clinical investigation.

[135]  Ray H. Baughman,et al.  Supporting Online Material , 2003 .

[136]  F. Marincola,et al.  Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function , 2009, Journal of Translational Medicine.